Abstract |
Tumors of the nervous system are among the most common and most chemoresistant neoplasms of childhood and adolescence. Malignant tumors of the brain collectively account for 21% of all cancers and 24% of all cancer-related deaths in this age group. Neuroblastoma, a peripheral nervous system tumor, is the most common extracranial solid tumor of childhood, and 65% of children with this tumor have only a 10 or 15% chance of living 5 years beyond the time of initial diagnosis. Novel pharmacological approaches to nervous system tumors are urgently needed. This review presents the role of and current challenges to pharmacotherapy of malignant tumors of the nervous system during childhood and adolescence and discusses novel approaches aimed at overcoming these challenges.
|
Authors | Nina F Schor |
Journal | Pharmacology & therapeutics
(Pharmacol Ther)
Vol. 122
Issue 1
Pg. 44-55
(Apr 2009)
ISSN: 1879-016X [Electronic] England |
PMID | 19318043
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Adolescent
- Animals
- Antineoplastic Agents
(pharmacology, therapeutic use)
- Brain Neoplasms
(drug therapy, mortality, physiopathology)
- Child
- Drug Resistance, Neoplasm
- Glioma
(drug therapy, mortality, physiopathology)
- Humans
- Neuroblastoma
(drug therapy, mortality, physiopathology)
- Spinal Cord Neoplasms
(drug therapy, mortality, physiopathology)
- Survival Rate
|